ArticlePloS one2022

Increased dosage and treatment time of Epigallocatechin-3-gallate (EGCG) negatively affects skeletal parameters in normal mice and Down syndrome mouse models.

Raza Jamal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.